Clinical Trial Supplies Market Report 2024-2034

Overall world revenue for Clinical Trial Supplies Market, 2024 to 2034 in terms of value the market will surpass US$ 4.10 billion in 2024. The publisher predicts strong revenue growth through to 2034. This work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

The Clinical Trial Supplies Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Opportunities in Emerging Markets Projected to Boost Industry Growth

Clinical trials are increasingly moving to developing economies like China, India, and Japan in the Asia Pacific region, with significant growth in patient recruitment in countries such as China, South Korea, and India due to lower costs compared to developed nations. Early phase clinical trials in developing nations are notably cheaper, making them an attractive option for pharmaceutical companies. For instance, in November 2023, AstraZeneca forged a partnership with a Chinese biotechnology company to secure a position in the competitive KRAS G12D field, exchanging $24 million upfront. The agreement grants AstraZeneca a worldwide license to UA022, a small molecule inhibitor targeting the historically challenging oncogene, which was undergoing preclinical development at Usynova. The Chinese biotech, in collaboration with partners such as WuXi AppTec, spearheaded the discovery and advancement of the molecule, ultimately determining that AstraZeneca's offer, which includes potential milestone payments totalling up to $395 million, was highly compelling and thus opted to accept it. Also, in November 2023, Novartis entered into an agreement with Chong Kun Dang Pharmaceutical, a biotechnology company based in Korea, for an early-stage HDAC6 Inhibitor. As per the contract terms, Novartis will provide an initial payment of $80 million and commit to additional development and regulatory milestone payments amounting to nearly $1.23 billion. These trends reflect a strategic shift towards countries offering lower operational expenses for clinical trials.

Challenges Posed by Lack of Comparator Sourcing

The clinical trial supplies market faces significant hurdles due to restrictions imposed by pharmaceutical manufacturers on procuring their products as comparators for clinical trials. These limitations typically encompass quantity constraints, prolonged approval procedures, and additional disclosure requirements, posing challenges for researchers and clinical trial supply chain management. Biologics, in particular, accentuate these difficulties as the lack of internal protocols and procedures from manufacturers exacerbates the situation. For instance, Sharp Clinical Services specializes in offering solutions for clinical trial supply chains, with a focus on comparator sourcing and supply. They cater to pharmaceutical companies conducting clinical trials, aiming to streamline the procurement process. Such firms play a pivotal role in addressing the challenges linked to comparator sourcing, thereby enhancing the efficiency of the clinical trial supply chain. Pharmaceutical manufacturers often impose strict quantity limits on procuring their products for use as comparators in clinical trials. Additionally, obtaining approval for these products can be time-consuming.

Key Questions Answered

How is the clinical trial supplies market evolving?
What is driving and restraining the clinical trial supplies market?
How will each clinical trial supplies submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
How will the market shares for each clinical trial supplies submarket develop from 2024 to 2034?
What will be the main driver for the overall market from 2024 to 2034?
Will leading clinical trial supplies markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
Who are the leading players and what are their prospects over the forecast period?
What are the clinical trial supplies projects for these leading companies?
How will the industry evolve during the period between 2024 and 2034? What are the implications of clinical trial supplies projects taking place now and over the next 10 years?
Is there a greater need for product commercialisation to further scale the clinical trial supplies market?
Where is the clinical trial supplies market heading and how can you ensure you are at the forefront of the market?
What are the best investment options for new product and service lines?
What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the clinical trial supplies market today, and over the next 10 years:

The 373-page report provides 155 tables and 243 charts/graphs exclusively to you.
The report highlights key lucrative areas in the industry so you can target them - NOW.
It contains in-depth analysis of global, regional and national sales and growth.
It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the clinical trial supplies market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, this new study provides you with recent results, growth rates, and market shares.
You will find original analyses, with business outlooks and developments.
Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising clinical trial supplies prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Location

Offshore Clinical Site
Domestic Clinical Site

Type

Small Molecule Products
Biologic Products
Medical Devices

Services

Manufacturing
Assays and Test Kits
IMPs and INDs
Placebos
Others
Packaging and Labelling
Logistics & Distribution
Cold Chain Distribution
Non-cold Chain Distribution
Storage & Retention
Comparator Sourcing
Other CTS Services

Therapeutic Areas

Oncology
CNS and Mental Disorders
Cardiovascular Disease (CVD)
Infectious Disease
Immunology Disease
Blood Disorders
Metabolic Disorders
Digestive Disorders
Other Therapeutic Areas

Phase

Phase I
Phase II
Phase III
Phase IV

End-users

Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs)
Medical Device Companies
Other End-users

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets:

North America

U.S.
Canada

Europe

Germany
UK
France
Spain
Italy
Russia
Rest of Europe

Asia Pacific

China
Japan
India
Australia
South Korea
Rest of Asia Pacific

Latin America

Brazil
Mexico
Argentina
Rest of Latin America

MEA

GCC
South Africa
Rest of MEA

The report also includes profiles and for some of the leading companies in the Clinical Trial Supplies Market, 2024 to 2034, with a focus on this segment of these companies’ operations.

Leading companies profiled in the report

Biocair
Bionical Limited
Catalent Inc.
Eurofins Scientific SE
ICON plc
IQVIA Holdings Inc.
KLIFO
Lonza Group AG
Marken
Parexel International
PCI Pharma Services
Sharp Services, LLC
Thermo Fisher Scientific Inc.
Walden Group SAS

How will the Clinical Trial Supplies Market, 2024 to 2034 report help you?

In summary, this 370+ page report provides you with the following knowledge:

Revenue forecasts to 2034 for Clinical Trial Supplies Market, 2024 to 2034, with forecasts for location, type, services, therapeutic areas, phase, and end-users, each forecast at a global and regional level - discover the industry’s prospects, finding the most lucrative places for investments and revenues.
Revenue forecasts to 2034 for five regional and 22 key national markets - See forecasts for the Clinical Trial Supplies Market, 2024 to 2034 market in North America, Europe, Asia Pacific, Latin America, and MEA. Also includes forecast for the market in the U.S., Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
Prospects for established firms and those seeking to enter the market - including company profiles for 14 of the major companies involved in the Clinical Trial Supplies Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only this report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how this work could benefit your research, analyses, and decisions. This study is for everybody needing commercial analyses for the Clinical Trial Supplies Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

1 Report Overview

1.1 Objectives of the Study
1.2 Introduction to Clinical Trial Supplies Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About the Publisher

2 Executive Summary

3 Market Overview

3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Growing Decentralisation of Clinical Trials
3.2.1.2 Increasing Number of Clinical Trials
3.2.1.3 Rising Demand for Biologics Propelling Growth of Cold Chain Distribution Supplies
3.2.1.4 Integration of Technical Solutions
3.2.1.5 Increasing Investments in the Development of Novel Pharmaceuticals
3.2.1.6 Technology Advancements are Propelling Market Expansion
3.2.2 Market Restraining Factors
3.2.2.1 Unavailability of Storage Facilities
3.2.2.2 Lack of Comparator Sourcing
3.2.2.3 High Costs Associated with Drug Developments
3.2.3 Market Opportunities
3.2.3.1 Emerging Economies Expansion and Prioritisation of R&D
3.2.3.2 Increasing Opportunities for Emerging Markets
3.2.3.3 Reduction in Clinical Trials Cost by using Supply Chain is Expected to Propel Market Growth
3.2.3.4 Collaboration and Partnerships among Clinical Trial Supplies Companies
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat of Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis

4 Clinical Trial Supplies Market Analysis by Location

4.1 Key Findings
4.2 Location Segment: Market Attractiveness Index
4.3 Clinical Trial Supplies Market Size Estimation and Forecast by Location
4.4 Offshore Clinical Site
4.4.1 Market Size by Region, 2024-2034 (US$ Million)
4.4.2 Market Share by Region, 2024 & 2034 (%)
4.5 Domestic Clinical Site
4.5.1 Market Size by Region, 2024-2034 (US$ Million)
4.5.2 Market Share by Region, 2024 & 2034 (%)

5 Clinical Trial Supplies Market Analysis by Type

5.1 Key Findings
5.2 Type Segment: Market Attractiveness Index
5.3 Clinical Trial Supplies Market Size Estimation and Forecast by Type
5.4 Small Molecule Products
5.4.1 Market Size by Region, 2024-2034 (US$ Million)
5.4.2 Market Share by Region, 2024 & 2034 (%)
5.5 Biologic Products
5.5.1 Market Size by Region, 2024-2034 (US$ Million)
5.5.2 Market Share by Region, 2024 & 2034 (%)
5.6 Medical Devices
5.6.1 Market Size by Region, 2024-2034 (US$ Million)
5.6.2 Market Share by Region, 2024 & 2034 (%)

6 Clinical Trial Supplies Market Analysis by Services

6.1 Key Findings
6.2 Services Segment: Market Attractiveness Index
6.3 Clinical Trial Supplies Market Size Estimation and Forecast by Services
6.4 Manufacturing
6.4.1 Market Size by Region, 2024-2034 (US$ Million)
6.4.2 Market Share by Region, 2024 & 2034 (%)
6.4.3 Assays and Test kits
6.4.3.1 Market Size by Region, 2024-2034 (US$ Million)
6.4.3.2 Market Share by Region, 2024 & 2034 (%)
6.4.4 IMPs and INDs
6.4.4.1 Market Size by Region, 2024-2034 (US$ Million)
6.4.4.2 Market Share by Region, 2024 & 2034 (%)
6.4.5 Placebos
6.4.5.1 Market Size by Region, 2024-2034 (US$ Million)
6.4.5.2 Market Share by Region, 2024 & 2034 (%)
6.4.6 Others
6.4.6.1 Market Size by Region, 2024-2034 (US$ Million)
6.4.6.2 Market Share by Region, 2024 & 2034 (%)
6.5 Packaging and Labelling
6.5.1 Market Size by Region, 2024-2034 (US$ Million)
6.5.2 Market Share by Region, 2024 & 2034 (%)
6.6 Logistics & Distribution
6.6.1 Market Size by Region, 2024-2034 (US$ Million)
6.6.2 Market Share by Region, 2024 & 2034 (%)
6.6.3 Cold Chain Distribution
6.6.3.1 Market Size by Region, 2024-2034 (US$ Million)
6.6.3.2 Market Share by Region, 2024 & 2034 (%)
6.6.4 Non-cold Chain Distribution
6.6.4.1 Market Size by Region, 2024-2034 (US$ Million)
6.6.4.2 Market Share by Region, 2024 & 2034 (%)
6.7 Storage & Retention
6.7.1 Market Size by Region, 2024-2034 (US$ Million)
6.7.2 Market Share by Region, 2024 & 2034 (%)
6.8 Comparator Sourcing
6.8.1 Market Size by Region, 2024-2034 (US$ Million)
6.8.2 Market Share by Region, 2024 & 2034 (%)
6.9 Other CTS Services
6.9.1 Market Size by Region, 2024-2034 (US$ Million)
6.9.2 Market Share by Region, 2024 & 2034 (%)

7 Clinical Trial Supplies Market Analysis by Therapeutic Areas

7.1 Key Findings
7.2 Therapeutic Areas Segment: Market Attractiveness Index
7.3 Clinical Trial Supplies Market Size Estimation and Forecast by Therapeutic Areas
7.4 Oncology
7.4.1 Market Size by Region, 2024-2034 (US$ Million)
7.4.2 Market Share by Region, 2024 & 2034 (%)
7.5 CNS and Mental Disorders
7.5.1 Market Size by Region, 2024-2034 (US$ Million)
7.5.2 Market Share by Region, 2024 & 2034 (%)
7.6 Cardiovascular Disease (CVD)
7.6.1 Market Size by Region, 2024-2034 (US$ Million)
7.6.2 Market Share by Region, 2024 & 2034 (%)
7.7 Infectious Disease
7.7.1 Market Size by Region, 2024-2034 (US$ Million)
7.7.2 Market Share by Region, 2024 & 2034 (%)
7.8 Immunology Disease
7.8.1 Market Size by Region, 2024-2034 (US$ Million)
7.8.2 Market Share by Region, 2024 & 2034 (%)
7.9 Blood Disorders
7.9.1 Market Size by Region, 2024-2034 (US$ Million)
7.9.2 Market Share by Region, 2024 & 2034 (%)
7.10 Metabolic Disorders
7.10.1 Market Size by Region, 2024-2034 (US$ Million)
7.10.2 Market Share by Region, 2024 & 2034 (%)
7.11 Digestive Disorders
7.11.1 Market Size by Region, 2024-2034 (US$ Million)
7.11.2 Market Share by Region, 2024 & 2034 (%)
7.12 Other Therapeutic Areas
7.12.1 Market Size by Region, 2024-2034 (US$ Million)
7.12.2 Market Share by Region, 2024 & 2034 (%)

8 Clinical Trial Supplies Market Analysis by Phase

8.1 Key Findings
8.2 Phases Segment: Market Attractiveness Index
8.3 Clinical Trial Supplies Market Size Estimation and Forecast by Phase
8.4 Phase I
8.4.1 Market Size by Region, 2024-2034 (US$ Million)
8.4.2 Market Share by Region, 2024 & 2034 (%)
8.5 Phase II
8.5.1 Market Size by Region, 2024-2034 (US$ Million)
8.5.2 Market Share by Region, 2024 & 2034 (%)
8.6 Phase III
8.6.1 Market Size by Region, 2024-2034 (US$ Million)
8.6.2 Market Share by Region, 2024 & 2034 (%)
8.7 Phase IV
8.7.1 Market Size by Region, 2024-2034 (US$ Million)
8.7.2 Market Share by Region, 2024 & 2034 (%)

9 Clinical Trial Supplies Market Analysis by End-users

9.1 Key Findings
9.2 End-users Segment: Market Attractiveness Index
9.3 Clinical Trial Supplies Market Size Estimation and Forecast by End-users
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Market Size by Region, 2024-2034 (US$ Million)
9.4.2 Market Share by Region, 2024 & 2034 (%)
9.5 Contract Research Organizations (CROs)
9.5.1 Market Size by Region, 2024-2034 (US$ Million)
9.5.2 Market Share by Region, 2024 & 2034 (%)
9.6 Medical Device Companies
9.6.1 Market Size by Region, 2024-2034 (US$ Million)
9.6.2 Market Share by Region, 2024 & 2034 (%)
9.7 Other End-users
9.7.1 Market Size by Region, 2024-2034 (US$ Million)
9.7.2 Market Share by Region, 2024 & 2034 (%)

10 Clinical Trial Supplies Market Analysis by Region

10.1 Key Findings
10.2 Regional Market Size Estimation and Forecast

11 North America Clinical Trial Supplies Market Analysis

11.1 Key Findings
11.2 North America Clinical Trial Supplies Market Attractiveness Index
11.3 North America Clinical Trial Supplies Market by Country, 2024, 2029 & 2034 (US$ Million)
11.4 North America Clinical Trial Supplies Market Size Estimation and Forecast by Country
11.5 North America Clinical Trial Supplies Market Size Estimation and Forecast by Location
11.6 North America Clinical Trial Supplies Market Size Estimation and Forecast by Type
11.7 North America Clinical Trial Supplies Market Size Estimation and Forecast by Services
11.7.1 North America Clinical Trial Supplies Market Size Estimation and Forecast by Manufacturing Services
11.7.2 North America Clinical Trial Supplies Market Size Estimation and Forecast by Logistics & Distribution Services
11.8 North America Clinical Trial Supplies Market Size Estimation and Forecast by Therapeutic Areas
11.9 North America Clinical Trial Supplies Market Size Estimation and Forecast by Phase
11.10 North America Clinical Trial Supplies Market Size Estimation and Forecast by End-users
11.11 U.S. Clinical Trial Supplies Market Analysis
11.12 Canada Clinical Trial Supplies Market Analysis

12 Europe Clinical Trial Supplies Market Analysis

12.1 Key Findings
12.2 Europe Clinical Trial Supplies Market Attractiveness Index
12.3 Europe Clinical Trial Supplies Market by Country, 2024, 2029 & 2034 (US$ Million)
12.4 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Country
12.5 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Location
12.6 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Type
12.7 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Services
12.7.1 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Manufacturing Services
12.7.2 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Logistics & Distribution Services
12.8 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Therapeutic Areas
12.9 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Phase
12.10 Europe Clinical Trial Supplies Market Size Estimation and Forecast by End-users
12.11 Germany Clinical Trial Supplies Market Analysis
12.12 UK Clinical Trial Supplies Market Analysis
12.13 France Clinical Trial Supplies Market Analysis
12.14 Italy Clinical Trial Supplies Market Analysis
12.15 Spain Clinical Trial Supplies Market Analysis
12.16 Russia Clinical Trial Supplies Market Analysis
12.17 Rest of Europe Clinical Trial Supplies Market Analysis

13 Asia Clinical Trial Supplies Market Analysis

13.1 Key Findings
13.2 Asia Clinical Trial Supplies Market Attractiveness Index
13.3 Asia Clinical Trial Supplies Market by Country, 2024, 2029 & 2034 (US$ Million)
13.4 Asia Clinical Trial Supplies Market Size Estimation and Forecast by Country
13.5 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Location
13.6 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Type
13.7 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Services
13.7.1 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Manufacturing Services
13.7.2 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Logistics & Distribution Services
13.8 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Therapeutic Areas
13.9 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Phase
13.10 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by End-users
13.11 Japan Clinical Trial Supplies Market Analysis
13.12 China Clinical Trial Supplies Market Analysis
13.13 India Clinical Trial Supplies Market Analysis
13.14 Australia Clinical Trial Supplies Market Analysis
13.15 South Korea Clinical Trial Supplies Market Analysis
13.16 Rest of Asia Clinical Trial Supplies Market Analysis

14 Latin America Clinical Trial Supplies Market Analysis

14.1 Key Findings
14.2 Latin America Clinical Trial Supplies Market Attractiveness Index
14.3 Latin America Clinical Trial Supplies Market by Country, 2024, 2029 & 2034 (US$ Million)
14.4 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Country
14.5 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Location
14.6 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Type
14.7 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Services
14.7.1 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Manufacturing Services
14.7.2 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Logistics & Distribution Services
14.8 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Therapeutic Areas
14.9 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Phase
14.10 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by End-users
14.11 Brazil Clinical Trial Supplies Market Analysis
14.12 Mexico Clinical Trial Supplies Market Analysis
14.13 Argentina Clinical Trial Supplies Market Analysis
14.14 Rest of Latin America Clinical Trial Supplies Market Analysis

15 MEA Clinical Trial Supplies Market Analysis

15.1 Key Findings
15.2 MEA Clinical Trial Supplies Market Attractiveness Index
15.3 MEA Clinical Trial Supplies Market by Country, 2024, 2029 & 2034 (US$ Million)
15.4 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Country
15.5 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Location
15.6 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Type
15.7 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Services
15.7.1 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Manufacturing Services
15.7.2 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Logistics & Distribution Services
15.8 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Therapeutic Areas
15.9 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Phase
15.10 MEA Clinical Trial Supplies Market Size Estimation and Forecast by End-users
15.11 GCC Clinical Trial Supplies Market Analysis
15.12 South Africa Clinical Trial Supplies Market Analysis
15.13 Rest of MEA Clinical Trial Supplies Market Analysis

16 Company Profiles

16.1 Competitive Landscape, 2023
16.2 Strategic Outlook
16.3 Thermo Fisher Scientific Inc.
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Financial Analysis
16.3.3.1 Net Revenue, 2018-2023
16.3.3.2 R&D, 2018-2023
16.3.3.3 Regional Market Shares, 2023
16.3.4 Service Benchmarking
16.3.5 Strategic Outlook
16.4 Catalent Inc.
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Financial Analysis
16.4.3.1 Net Revenue, 2018-2023
16.4.3.2 Regional Market Shares, 2023
16.4.4 Service Benchmarking
16.4.5 Strategic Outlook
16.5 IQVIA Holdings Inc
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Financial Analysis
16.5.3.1 Net Revenue, 2018-2023
16.5.3.2 Regional Market Shares, 2023
16.5.4 Service Benchmarking
16.5.5 Strategic Outlook
16.6 Marken
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Service Benchmarking
16.6.4 Strategic Outlook
16.7 Eurofins Scientific SE
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Financial Analysis
16.7.3.1 Net Revenue, 2018-2023
16.7.3.2 Regional Market Shares, 2023
16.7.4 Service Benchmarking
16.7.5 Strategic Outlook
16.8 ICON Plc
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Financial Analysis
16.8.3.1 Net Revenue, 2017-2022
16.8.3.2 Regional Market Shares, 2023
16.8.4 Service Benchmarking
16.8.5 Strategic Outlook
16.9 Parexel International
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Service Benchmarking
16.9.4 Strategic Outlook
16.10 Lonza Group AG
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Financial Analysis
16.10.3.1 Net Revenue, 2018-2023
16.10.3.2 Regional Market Shares, 2023
16.10.4 Service Benchmarking
16.10.5 Strategic Outlook
16.11 Biocair
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Service Benchmarking
16.11.4 Strategic Outlook
16.12 KLIFO
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Financial Analysis
16.12.3.1 Net Revenue, 2018-2023
16.12.4 Service Benchmarking
16.12.5 Strategic Outlook
16.13 Walden Group SAS
16.13.1 Company Snapshot
16.13.2 Company Overview
16.13.3 Service Benchmarking
16.13.4 Strategic Outlook
16.14 PCI Pharma Services
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Service Benchmarking
16.15 Sharp Services, LLC
16.15.1 Company Snapshot
16.15.2 Company Overview
16.15.3 Financial Analysis
16.15.3.1 Net Revenue, 2017-2022
16.15.3.2 Regional Market Shares, 2023
16.15.4 Service Benchmarking
16.15.5 Strategic Outlook
16.16 Bionical Limited
16.16.1 Company Snapshot
16.16.2 Company Overview
16.16.3 Service Benchmarking

17 Conclusion and Recommendations

17.1 Concluding Remarks from the Publisher
17.2 Recommendations for Market Players

List of Tables

Table 1 Clinical Trial Supplies Market Snapshot, 2024 & 2034 (US$ Million, CAGR %)
Table 2 Number of Clinical Trials by Therapeutic Area, 2023
Table 3 Clinical Trial Supplies Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): “V” Shaped Recovery
Table 4 Clinical Trial Supplies Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): “U” Shaped Recovery
Table 5 Clinical Trial Supplies Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): “W” Shaped Recovery
Table 6 Clinical Trial Supplies Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): “L” Shaped Recovery
Table 7 Clinical Trial Supplies Market Forecast by Location, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 8 Offshore Clinical Site Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 9 Domestic Clinical Site Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 10 Clinical Trial Supplies Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 11 Small Molecule Products Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 12 Biologic Products Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 13 Medical Devices Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 14 Clinical Trial Supplies Market Forecast by Services, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 15 Manufacturing Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 16 Assays and Test Kits Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 17 IMPs and INDs Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 18 Placebos Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 19 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 20 Packaging and Labeling Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 21 Logistics & Distribution Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 22 Cold Chain Distribution Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 23 Non-cold Chain Distribution Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 24 Storage & Retention Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 25 Comparator Sourcing Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 26 Other CTS Services Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 27 Clinical Trial Supplies Market Forecast by Therapeutic Areas, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 28 Oncology Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 29 CNS and Mental Disorders Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 30 Cardiovascular Disease (CVD) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 31 Infectious Disease Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 32 Immunology Disease Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 33 Blood Disorders Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 34 Metabolic Disorders Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 35 Digestive Disorders Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 36 Other Therapeutic Areas Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 37 Clinical Trial Supplies Market Forecast by Phase, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 38 Phase I Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 39 Phase II Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 40 Phase III Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 41 Phase IV Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 42 Clinical Trial Supplies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 43 Pharmaceutical and Biotechnology Companies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 44 Contract Research Organizations (CROs) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 45 Medical Device Companies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 46 Other End-users Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 47 Clinical Trial Supplies Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 48 North America Clinical Trial Supplies Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 49 North America Clinical Trial Supplies Market Forecast by Location, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 50 North America Clinical Trial Supplies Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 51 North America Clinical Trial Supplies Market Forecast by Services, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 52 North America Clinical Trial Supplies Market Forecast by Manufacturing Services, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 53 North America Clinical Trial Supplies Market Forecast by Logistics & Distribution Services, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 54 North America Clinical Trial Supplies Market Forecast by Therapeutic Areas, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 55 North America Clinical Trial Supplies Market Forecast by Phase, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 56 North America Clinical Trial Supplies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 57 U.S. Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 58 Canada Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 59 Europe Clinical Trial Supplies Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 60 Europe Clinical Trial Supplies Market Forecast by Location, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 61 Europe Clinical Trial Supplies Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 62 Europe Clinical Trial Supplies Market Forecast by Services, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 63 Europe Clinical Trial Supplies Market Forecast by Manufacturing Services, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 64 Europe Clinical Trial Supplies Market Forecast by Logistics & Distribution Services, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 65 Europe Clinical Trial Supplies Market Forecast by Therapeutic Areas, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 66 Europe Clinical Trial Supplies Market Forecast by Phase, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 67 Europe Clinical Trial Supplies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 68 Germany Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 69 UK Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 70 France Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 71 Italy Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 72 Spain Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 73 Russia Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 74 Rest of Europe Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 75 Asia Clinical Trial Supplies Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 76 Asia Pacific Clinical Trial Supplies Market Forecast by Location, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 77 Asia Pacific Clinical Trial Supplies Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 78 Asia Pacific Clinical Trial Supplies Market Forecast by Services, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 79 Asia Pacific Clinical Trial Supplies Market Forecast by Manufacturing Services, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 80 Asia Pacific Clinical Trial Supplies Market Forecast by Logistics & Distribution Services, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 81 Asia Pacific Clinical Trial Supplies Market Forecast by Therapeutic Areas, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 82 Asia Pacific Clinical Trial Supplies Market Forecast by Phase, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 83 Asia Pacific Clinical Trial Supplies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 84 Japan Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 85 China Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 86 India Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 87 Australia Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 88 South Korea Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 89 Rest of Asia Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 90 Latin America Clinical Trial Supplies Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 91 Latin America Clinical Trial Supplies Market Forecast by Location, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 92 Latin America Clinical Trial Supplies Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 93 Latin America Clinical Trial Supplies Market Forecast by Services, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 94 Latin America Clinical Trial Supplies Market Forecast by Manufacturing Services, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 95 Latin America Clinical Trial Supplies Market Forecast by Logistics & Distribution Services, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 96 Latin America Clinical Trial Supplies Market Forecast by Therapeutic Areas, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 97 Latin America Clinical Trial Supplies Market Forecast by Phase, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 98 Latin America Clinical Trial Supplies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 99 Brazil Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 100 Mexico Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 101 Argentina Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 102 Rest of Latin America Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 103 MEA Clinical Trial Supplies Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 104 MEA Clinical Trial Supplies Market Forecast by Location, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 105 MEA Clinical Trial Supplies Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 106 MEA Clinical Trial Supplies Market Forecast by Services, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 107 MEA Clinical Trial Supplies Market Forecast by Manufacturing Services, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 108 MEA Clinical Trial Supplies Market Forecast by Logistics & Distribution Services, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 109 MEA Clinical Trial Supplies Market Forecast by Therapeutic Areas, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 110 MEA Clinical Trial Supplies Market Forecast by Phase, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 111 MEA Clinical Trial Supplies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 112 GCC Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 113 South Africa Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 114 Rest of MEA Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 115 Strategic Outlook
Table 116 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 Thermo Fisher Scientific Inc.: Service Benchmarking
Table 118 Thermo Fisher Scientific Inc.: Strategic Outlook
Table 119 Catalent Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 120 Catalent Inc.: Service Benchmarking
Table 121 Catalent Inc.: Strategic Outlook
Table 122 IQVIA Holdings Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 123 IQVIA Holdings Inc: Service Benchmarking
Table 124 IQVIA: Strategic Outlook
Table 125 Marken: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 126 Marken: Service Benchmarking
Table 127 Marken: Strategic Outlook
Table 128 Eurofins Scientific SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 129 Eurofins Scientific SE: Service Benchmarking
Table 130 Eurofins Scientific SE: Strategic Outlook
Table 131 ICON Plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 132 ICON Plc: Service Benchmarking
Table 133 ICON Plc: Strategic Outlook
Table 134 Parexel International: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 135 Parexel International: Service Benchmarking
Table 136 Parexel International: Strategic Outlook
Table 137 Lonza Group AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 138 Lonza Group AG: Service Benchmarking
Table 139 Lonza Group AG: Strategic Outlook
Table 140 Biocair: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 141 Biocair: Service Benchmarking
Table 142 Biocair: Strategic Outlook
Table 143 KLIFO: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 144 KLIFO: Service Benchmarking
Table 145 KLIFO: Strategic Outlook
Table 146 Walden Group SAS: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 147 Walden Group SAS: Service Benchmarking
Table 148 Walden Group SAS: Strategic Outlook
Table 149 PCI Pharma Services: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 150 PCI Pharma Services: Service Benchmarking
Table 151 Sharp Services, LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 152 Sharp Services, LLC: Service Benchmarking
Table 153 Sharp Services, LLC: Strategic Outlook
Table 154 Bionical Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 155 Bionical Limited: Service Benchmarking

List of Figures

Figure 1 Clinical Trial Supplies Market Segmentation
Figure 2 Clinical Trial Supplies Market by Location: Market Attractiveness Index
Figure 3 Clinical Trial Supplies Market by Type: Market Attractiveness Index
Figure 4 Clinical Trial Supplies Market by Services: Market Attractiveness Index
Figure 5 Clinical Trial Supplies Market by Therapeutic Areas: Market Attractiveness Index
Figure 6 Clinical Trial Supplies Market by Phase: Market Attractiveness Index
Figure 7 Clinical Trial Supplies Market by End-users: Market Attractiveness Index
Figure 8 Clinical Trial Supplies Market Attractiveness Index by Region
Figure 9 Clinical Trial Supplies Market: Market Dynamics
Figure 10 Clinical Trial Supplies Market by Region, 2024-2034 (US$ Million, AGR %): “V” Shaped Recovery
Figure 11 Clinical Trial Supplies Market by Region, 2024-2034 (US$ Million, AGR %): “U” Shaped Recovery
Figure 12 Clinical Trial Supplies Market by Region, 2024-2034 (US$ Million, AGR %): “W” Shaped Recovery
Figure 13 Clinical Trial Supplies Market by Region, 2024-2034 (US$ Million, AGR %): “L” Shaped Recovery
Figure 14 Clinical Trial Supplies Market: Porter’s Five Forces Analysis
Figure 15 Clinical Trial Supplies Market: PEST Analysis
Figure 16 Clinical Trial Supplies Market by Location: Market Attractiveness Index
Figure 17 Clinical Trial Supplies Market Forecast by Location, 2024-2034 (US$ Million, AGR %)
Figure 18 Clinical Trial Supplies Share Forecast by Location, 2024, 2029, 2034 (%)
Figure 19 Offshore Clinical Site Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 20 Offshore Clinical Site Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 21 Domestic Clinical Site Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 22 Domestic Clinical Site Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 23 Clinical Trial Supplies Market by Type: Market Attractiveness Index
Figure 24 Clinical Trial Supplies Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 25 Clinical Trial Supplies Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 26 Small Molecule Products Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 27 Small Molecule Products Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 28 Biologic Products Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 29 Biologic Products Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 30 Medical Devices Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 31 Medical Devices Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 32 Clinical Trial Supplies Market by Services: Market Attractiveness Index
Figure 33 Clinical Trial Supplies Market Forecast by Services, 2024-2034 (US$ Million, AGR %)
Figure 34 Clinical Trial Supplies Share Forecast by Services, 2024, 2029, 2034 (%)
Figure 35 Manufacturing Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 36 Manufacturing Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 37 Assays and Test Kits Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 38 Assays and Test Kits Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 39 IMPs and INDs Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 40 IMPs and INDs Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 41 Placebos Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 42 Placebos Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 43 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 44 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 45 Packaging and Labeling Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 46 Packaging and Labeling Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 47 Logistics & Distribution Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 48 Logistics & Distribution Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 49 Cold Chain Distribution Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 50 Cold Chain Distribution Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 51 Non-cold Chain Distribution Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 52 Non-cold Chain Distribution Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 53 Storage & Retention Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 54 Storage & Retention Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 55 Comparator Sourcing Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 56 Comparator Sourcing Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 57 Other CTS Services Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 58 Other CTS Services Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 59 Clinical Trial Supplies Market by Therapeutic Areas: Market Attractiveness Index
Figure 60 Clinical Trial Supplies Market Forecast by Therapeutic Areas, 2024-2034 (US$ Million, AGR %)
Figure 61 Clinical Trial Supplies Share Forecast by Therapeutic Areas, 2024, 2029, 2034 (%)
Figure 62 Oncology Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 63 Oncology Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 64 CNS and Mental Disorders Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 65 CNS and Mental Disorders Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 66 Cardiovascular Disease (CVD) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 67 Cardiovascular Disease (CVD) Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 68 Infectious Disease Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 69 Infectious Disease Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 70 Immunology Disease Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 71 Immunology Disease Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 72 Blood Disorders Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 73 Blood Disorders Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 74 Metabolic Disorders Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 75 Metabolic Disorders Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 76 Digestive Disorders Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 77 Digestive Disorders Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 78 Other Therapeutic Areas Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 79 Other Therapeutic Areas Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 80 Clinical Trial Supplies Market by Phase: Market Attractiveness Index
Figure 81 Clinical Trial Supplies Market Forecast by Phase, 2024-2034 (US$ Million, AGR %)
Figure 82 Clinical Trial Supplies Share Forecast by Phase, 2024, 2029, 2034 (%)
Figure 83 Phase I Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 84 Phase I Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 85 Phase II Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 86 Phase II Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 87 Phase III Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 88 Phase III Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 89 Phase IV Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 90 Phase IV Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 91 Clinical Trial Supplies Market by End-users: Market Attractiveness Index
Figure 92 Clinical Trial Supplies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
Figure 93 Clinical Trial Supplies Share Forecast by End-users, 2024, 2029, 2034 (%)
Figure 94 Pharmaceutical and Biotechnology Companies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 95 Pharmaceutical and Biotechnology Companies Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 96 Contract Research Organizations (CROs) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 97 Contract Research Organizations (CROs) Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 98 Medical Device Companies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 99 Medical Device Companies Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 100 Other End-users Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 101 Other End-users Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 102 Clinical Trial Supplies Market Forecast by Region 2024 and 2034 (Revenue, CAGR%)
Figure 103 Clinical Trial Supplies Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 104 Clinical Trial Supplies Market by Region, 2024-2034 (US$ Million, AGR %)
Figure 105 North America Clinical Trial Supplies Market Attractiveness Index
Figure 106 North America Clinical Trial Supplies Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 107 North America Clinical Trial Supplies Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 108 North America Clinical Trial Supplies Market Share Forecast by Country, 2024 & 2034 (%)
Figure 109 North America Clinical Trial Supplies Market Forecast by Location, 2024-2034 (US$ Million, AGR %)
Figure 110 North America Clinical Trial Supplies Market Share Forecast by Location, 2024 & 2034 (%)
Figure 111 North America Clinical Trial Supplies Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 112 North America Clinical Trial Supplies Market Share Forecast by Type, 2024 & 2034 (%)
Figure 113 North America Clinical Trial Supplies Market Forecast by Services, 2024-2034 (US$ Million, AGR %)
Figure 114 North America Clinical Trial Supplies Market Share Forecast by Services, 2024 & 2034 (%)
Figure 115 North America Clinical Trial Supplies Market Forecast by Manufacturing Services, 2024-2034 (US$ Million, AGR %)
Figure 116 North America Clinical Trial Supplies Market Share Forecast by Manufacturing Services, 2024 & 2034 (%)
Figure 117 North America Clinical Trial Supplies Market Forecast by Logistics & Distribution Services, 2024-2034 (US$ Million, AGR %)
Figure 118 North America Clinical Trial Supplies Market Share Forecast by Manufacturing Services, 2024 & 2034 (%)
Figure 119 North America Clinical Trial Supplies Market Forecast by Therapeutic Areas, 2024-2034 (US$ Million, AGR %)
Figure 120 North America Clinical Trial Supplies Market Share Forecast by Therapeutic Areas, 2024 & 2034 (%)
Figure 121 North America Clinical Trial Supplies Market Forecast by Phase, 2024-2034 (US$ Million, AGR %)
Figure 122 North America Clinical Trial Supplies Market Share Forecast by Phase, 2024 & 2034 (%)
Figure 123 North America Clinical Trial Supplies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
Figure 124 North America Clinical Trial Supplies Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 125 U.S. Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 126 Canada Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 127 Europe Clinical Trial Supplies Market Attractiveness Index
Figure 128 Europe Clinical Trial Supplies Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 129 Europe Clinical Trial Supplies Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 130 Europe Clinical Trial Supplies Market Share Forecast by Country, 2024 & 2034 (%)
Figure 131 Europe Clinical Trial Supplies Market Forecast by Location, 2024-2034 (US$ Million, AGR %)
Figure 132 Europe Clinical Trial Supplies Market Share Forecast by Location, 2024 & 2034 (%)
Figure 133 Europe Clinical Trial Supplies Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 134 Europe Clinical Trial Supplies Market Share Forecast by Type, 2024 & 2034 (%)
Figure 135 Europe Clinical Trial Supplies Market Forecast by Services, 2024-2034 (US$ Million, AGR %)
Figure 136 Europe Clinical Trial Supplies Market Share Forecast by Services, 2024 & 2034 (%)
Figure 137 Europe Clinical Trial Supplies Market Forecast by Manufacturing Services, 2024-2034 (US$ Million, AGR %)
Figure 138 Europe Clinical Trial Supplies Market Share Forecast by Manufacturing Services, 2024 & 2034 (%)
Figure 139 Europe Clinical Trial Supplies Market Forecast by Logistics & Distribution Services, 2024-2034 (US$ Million, AGR %)
Figure 140 Europe Clinical Trial Supplies Market Share Forecast by Manufacturing Services, 2024 & 2034 (%)
Figure 141 Europe Clinical Trial Supplies Market Forecast by Therapeutic Areas, 2024-2034 (US$ Million, AGR %)
Figure 142 Europe Clinical Trial Supplies Market Share Forecast by Therapeutic Areas, 2024 & 2034 (%)
Figure 143 Europe Clinical Trial Supplies Market Forecast by Phase, 2024-2034 (US$ Million, AGR %)
Figure 144 Europe Clinical Trial Supplies Market Share Forecast by Phase, 2024 & 2034 (%)
Figure 145 Europe Clinical Trial Supplies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
Figure 146 Europe Clinical Trial Supplies Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 147 Germany Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 148 UK Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 149 France Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 150 Italy Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 151 Spain Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 152 Russia Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 153 Rest of Europe Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 154 Asia Clinical Trial Supplies Market Attractiveness Index
Figure 155 Asia Clinical Trial Supplies Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 156 Asia Clinical Trial Supplies Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 157 Asia Clinical Trial Supplies Market Share Forecast by Country, 2024 & 2034 (%)
Figure 158 Asia Pacific Clinical Trial Supplies Market Forecast by Location, 2024-2034 (US$ Million, AGR %)
Figure 159 Asia Pacific Clinical Trial Supplies Market Share Forecast by Location, 2024 & 2034 (%)
Figure 160 Asia Pacific Clinical Trial Supplies Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 161 Asia Pacific Clinical Trial Supplies Market Share Forecast by Type, 2024 & 2034 (%)
Figure 162 Asia Pacific Clinical Trial Supplies Market Forecast by Services, 2024-2034 (US$ Million, AGR %)
Figure 163 Asia Pacific Clinical Trial Supplies Market Share Forecast by Services, 2024 & 2034 (%)
Figure 164 Asia Pacific Clinical Trial Supplies Market Forecast by Manufacturing Services, 2024-2034 (US$ Million, AGR %)
Figure 165 Asia Pacific Clinical Trial Supplies Market Share Forecast by Manufacturing Services, 2024 & 2034 (%)
Figure 166 Asia Pacific Clinical Trial Supplies Market Forecast by Logistics & Distribution Services, 2024-2034 (US$ Million, AGR %)
Figure 167 Asia Pacific Clinical Trial Supplies Market Share Forecast by Manufacturing Services, 2024 & 2034 (%)
Figure 168 Asia Pacific Clinical Trial Supplies Market Forecast by Therapeutic Areas, 2024-2034 (US$ Million, AGR %)
Figure 169 Asia Pacific Clinical Trial Supplies Market Share Forecast by Therapeutic Areas, 2024 & 2034 (%)
Figure 170 Asia Pacific Clinical Trial Supplies Market Forecast by Phase, 2024-2034 (US$ Million, AGR %)
Figure 171 Asia Pacific Clinical Trial Supplies Market Share Forecast by Phase, 2024 & 2034 (%)
Figure 172 Asia Pacific Clinical Trial Supplies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
Figure 173 Asia Pacific Clinical Trial Supplies Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 174 Japan Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 175 China Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 176 India Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 177 Australia Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 178 South Korea Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 179 Rest of Asia Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 180 Latin America Clinical Trial Supplies Market Attractiveness Index
Figure 181 Latin America Clinical Trial Supplies Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 182 Latin America Clinical Trial Supplies Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 183 Latin America Clinical Trial Supplies Market Share Forecast by Country, 2024 & 2034 (%)
Figure 184 Latin America Clinical Trial Supplies Market Forecast by Location, 2024-2034 (US$ Million, AGR %)
Figure 185 Latin America Clinical Trial Supplies Market Share Forecast by Location, 2024 & 2034 (%)
Figure 186 Latin America Clinical Trial Supplies Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 187 Latin America Clinical Trial Supplies Market Share Forecast by Type, 2024 & 2034 (%)
Figure 188 Latin America Clinical Trial Supplies Market Forecast by Services, 2024-2034 (US$ Million, AGR %)
Figure 189 Latin America Clinical Trial Supplies Market Share Forecast by Services, 2024 & 2034 (%)
Figure 190 Latin America Clinical Trial Supplies Market Forecast by Manufacturing Services, 2024-2034 (US$ Million, AGR %)
Figure 191 Latin America Clinical Trial Supplies Market Share Forecast by Manufacturing Services, 2024 & 2034 (%)
Figure 192 Latin America Clinical Trial Supplies Market Forecast by Logistics & Distribution Services, 2024-2034 (US$ Million, AGR %)
Figure 193 Latin America Clinical Trial Supplies Market Share Forecast by Manufacturing Services, 2024 & 2034 (%)
Figure 194 Latin America Clinical Trial Supplies Market Forecast by Therapeutic Areas, 2024-2034 (US$ Million, AGR %)
Figure 195 Latin America Clinical Trial Supplies Market Share Forecast by Therapeutic Areas, 2024 & 2034 (%)
Figure 196 Latin America Clinical Trial Supplies Market Forecast by Phase, 2024-2034 (US$ Million, AGR %)
Figure 197 Latin America Clinical Trial Supplies Market Share Forecast by Phase, 2024 & 2034 (%)
Figure 198 Latin America Clinical Trial Supplies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
Figure 199 Latin America Clinical Trial Supplies Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 200 Brazil Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 201 Mexico Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 202 Argentina Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 203 Rest of Latin America Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 204 MEA Clinical Trial Supplies Market Attractiveness Index
Figure 205 MEA Clinical Trial Supplies Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 206 MEA Clinical Trial Supplies Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 207 MEA Clinical Trial Supplies Market Share Forecast by Country, 2024 & 2034 (%)
Figure 208 MEA Clinical Trial Supplies Market Forecast by Location, 2024-2034 (US$ Million, AGR %)
Figure 209 MEA Clinical Trial Supplies Market Share Forecast by Location, 2024 & 2034 (%)
Figure 210 MEA Clinical Trial Supplies Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 211 MEA Clinical Trial Supplies Market Share Forecast by Type, 2024 & 2034 (%)
Figure 212 MEA Clinical Trial Supplies Market Forecast by Services, 2024-2034 (US$ Million, AGR %)
Figure 213 MEA Clinical Trial Supplies Market Share Forecast by Services, 2024 & 2034 (%)
Figure 214 MEA Clinical Trial Supplies Market Forecast by Manufacturing Services, 2024-2034 (US$ Million, AGR %)
Figure 215 MEA Clinical Trial Supplies Market Share Forecast by Manufacturing Services, 2024 & 2034 (%)
Figure 216 MEA Clinical Trial Supplies Market Forecast by Logistics & Distribution Services, 2024-2034 (US$ Million, AGR %)
Figure 217 MEA Clinical Trial Supplies Market Share Forecast by Manufacturing Services, 2024 & 2034 (%)
Figure 218 MEA Clinical Trial Supplies Market Forecast by Therapeutic Areas, 2024-2034 (US$ Million, AGR %)
Figure 219 MEA Clinical Trial Supplies Market Share Forecast by Therapeutic Areas, 2024 & 2034 (%)
Figure 220 MEA Clinical Trial Supplies Market Forecast by Phase, 2024-2034 (US$ Million, AGR %)
Figure 221 MEA Clinical Trial Supplies Market Share Forecast by Phase, 2024 & 2034 (%)
Figure 222 MEA Clinical Trial Supplies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
Figure 223 MEA Clinical Trial Supplies Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 224 GCC Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 225 South Africa Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 226 Rest of MEA Clinical Trial Supplies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 227 Clinical Trial Supplies Market: Company Share, 2023
Figure 228 Thermo Fisher Scientific Inc.: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 229 Thermo Fisher Scientific Inc.: R&D, 2018-2023 (US$ Million, AGR%)
Figure 230 Thermo Fisher Scientific Inc.: Regional Market Shares, 2023
Figure 231 Catalent Inc.: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 232 Catalent Inc.: Regional Market Shares, 2023
Figure 233 IQVIA Holdings Inc: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 234 IQVIA Holdings Inc: Regional Market Shares, 2023
Figure 235 Eurofins Scientific SE: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 236 Eurofins Scientific SE: Regional Market Shares, 2023
Figure 237 ICON Plc: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 238 ICON Plc: Regional Market Shares, 2023
Figure 239 Lonza Group AG: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 240 Lonza Group AG: Regional Market Shares, 2023
Figure 241 KLIFO: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 242 Sharp Services, LLC: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 243 Sharp Services, LLC: Regional Market Shares, 2023

Companies Mentioned

Biocair
Bionical Limited
Catalent Inc.
Eurofins Scientific SE
ICON plc
IQVIA Holdings Inc.
KLIFO
Lonza Group AG
Marken
Parexel International
PCI Pharma Services
Sharp Services, LLC
Thermo Fisher Scientific Inc.
Walden Group SAS
AbCellera Clinical Trial Supplies Ltd.
Adagene
Alphora Inc.
Anima Biotech
Astellas Pharma
Aurinia Pharmaceuticals
Bayer
BioCity
Biohaven Pharmaceuticals
BioNet
BioNTech
Blackstone Life Sciences
Boehringer Ingelheim
Checkmate
Chongqing Zhifei Biological Products, Ltd.
Clinical Trial Supplies
Coherus Bioscience
Daiichi Sankyo
Decibel Therapeutics
DICE Therapeutics
Eisai Co., Ltd.
Embark Biotech
Eurofins
Forma Therapeutics Holdings, Inc.
Genentech
Genovac
Genuv
Good Therapeutics
Horizon Therapeutics
Imago BioSciences, Inc.
Immunome
Innovent
Innovent Clinical Trial Supplies
Janssen Pharmaceutical
Kite Pharma
Lonza
Lyvgen
MacroGenics
Mersana
MindBeacon
Moderna
Motorica
Neupogen
Neurimmune
Neuronix
Novavax, Inc.
NVDIA
Pfizer
Prometheus Biosciences
Provention Bio
Repare Therapeutics
ReViral
Richter-Helm BioLogics GmbH & Co. KG
Roivant
RQ Biotechnology
Samsung Bioepis
Sandoz
Seagen
Sigilon Therapeutics
Sironax
Takeda
Thermo Fisher Scientific
Think Research
UCB Pharma
Versanis Bio
Viatris
Zenas BioPharma
AusBiotech
Australian Biotechnology Association
Biomedical Advanced Research and Development Authority (BARDA)
BioVentures
British Columbia
Canada Government
Dubai Health Authority
European Commission (EC)
European Medicines Agency (EMA)
International Trade Administration U.S. Department of Commerce
Ministry of Health and Family Welfare
National Agency for the Promotion of Science and Technology (ANPCyT)
National Center for Biotechnology Information (NCBI)
Newton Biocapital
National Institutes of Health (NIH)
NHS Foundation Trust
Nippon Venture Capital
OneBio Seed Investment Fund
Shinsei Capital Partners
The SoftBank Group
U.S. Department of Health and Human Services (HHS)
U.S. Food and Drug Administration (FDA)
World Health Organization (WHO)
Wisconsin Economic Development Corporation, Mexico
World Bank
World Cancer Research Fund International

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5396EUR$5,688USD£4,350GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€6388EUR$6,734USD£5,150GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€7505EUR$7,911USD£6,050GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€9483EUR$9,996USD£7,645GBP